A review of renal, cardiovascular and mortality endpoints in antihypertensive trials in diabetic patients

Author： García-Donaire J. A.   Segura J.   Cerezo C.   Ruilope L. M.  

Publisher： Informa Healthcare

ISSN： 0803-7051

Source： Blood Pressure, Vol.20, Iss.6, 2011-12, pp. : 322-334

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sympathetic Overactivity in Patients with Chronic Renal Failure - The Culprit of Increased Cardiovascular Mortality?

By  

Current Hypertension Reviews, Vol. 2, Iss. 4, 2006-11 ,pp. : 297-300

Bentham Science Publishers

Access to resources Recommend Favorite

The impact of ACE inhibition on all-cause and cardiovascular mortality in contemporary hypertension trials: a review

By Ferrari Roberto   Boersma Eric  

Expert Review of Cardiovascular Therapy, Vol. 11, Iss. 6, 2013-06 ,pp. : 705-717

Informa Healthcare

Access to resources Recommend Favorite

A Systematic Review of Randomized Controlled Trials Examining the Nephroprotective Properties of Antihypertensive Medications

By  

Current Hypertension Reviews, Vol. 8, Iss. 3, 2012-08 ,pp. : 196-226

Bentham Science Publishers

Access to resources Recommend Favorite

Are we overtreating cardiovascular disease in diabetic patients?

By Mosseri Morris   Arnson Yoav   Raz Itamar  

Diabetes Management, Vol. 3, Iss. 4, 2013-07 ,pp. : 271-275

Future Medicine

Access to resources Recommend Favorite

A Review on Electrocardiographic Changes in Diabetic Patients

By  

Current Diabetes Reviews, Vol. 11, Iss. 2, 2015-06 ,pp. : 102-106

Bentham Science Publishers

Access to resources Recommend Favorite